Celldex Therapeutics Inc (CLDX)
SG&A Expense Growth
14.45%
Quarterly · Period ending:
CLDX SG&A Expense Growth
Latest reported14.45%period ending
Latest reported14.45%period ending
CLDX Quarterly SG&A Growth (QoQ) (0.00% → 14.45%)
Latest values, visible window
High-resolution chart · PNG
CLDX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -2.1494% | |
| -24.7412% | |
| 53.5935% | |
| 0.8254% | |
| -5.488% | |
| -30.2367% | |
| 97.525% | |
| -20% | |
| 0% | |
| -28.5714% | |
| 55.5556% | |
| 28.5714% | |
| -12.5% | |
| 0% | |
| -11.1111% | |
| -18.1818% | |
| 37.5% | |
| -42.8571% | |
| 55.5556% | |
| -71.875% | |
| 220% | |
| -37.5% | |
| 0% | |
| 23.0769% | |
| -7.1429% | |
| 7.6923% | |
| 0% | |
| -23.5294% | |
| 13.3333% | |
| -60.5263% | |
| -9.5238% | |
| 2.439% | |
| 5.1282% | |
| 0% | |
| 14.7059% | |
| -12.8205% | |
| 11.4286% | |
| 6.0606% | |
| 10% | |
| -6.25% | |
| 0% | |
| 0% | |
| -3.0303% | |
| 10% | |
| -9.0909% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |